The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease
Theranostics · 2024
DOI: 10.7150/thno.98457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Jieyi Meng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China. Hauptthemen laut MEDLINE: Parkinson Disease, NF-E2-Related Factor 2, Molecular Chaperones, Dopaminergic Neurons. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rationale
Ferroptosis-driven loss of dopaminergic neurons plays a pivotal role in the pathogenesis of Parkinson's disease (PD). In PD patients, Hspb1 is commonly observed at abnormally high levels in the substantia nigra. The precise consequences of Hspb1 overexpression in PD, however, have yet to be fully elucidated.
Methods
We used human iPSC-derived dopaminergic neurons and Coniferaldehyde (CFA)-an Nrf2 agonist known for its ability to cross the blood-brain barrier-to investigate the role of Hspb1 in PD. We examined the correlation between Hspb1 overexpression and Nrf2 activation and explored the transcriptional regulation of Hspb1 by Nrf2. Gene deletion techniques were employed to determine the necessity of Nrf2 and Hspb1 for CFA's neuroprotective effects.
Results
Our research demonstrated that Nrf2 can upregulate the transcription of Hspb1 by directly binding to its promoter. Deletion of either Nrf2 or Hspb1 gene abolished the neuroprotective effects of CFA. The Nrf2-Hspb1 pathway, newly identified as a defense mechanism against ferroptosis, was shown to be essential for preventing neurodegeneration progression. Additionally, we discovered that prolonged overexpression of Hspb1 leads to neuronal death and that Hspb1 released from ruptured cells can trigger secondary cell death in neighboring cells, exacerbating neuroinflammatory responses.
Conclusions
These findings highlight a biphasic role of Hspb1 in PD, where it initially provides neuroprotection through the Nrf2-Hspb1 pathway but ultimately contributes to neurodegeneration and inflammation when overexpressed. Understanding this dual role is crucial for developing therapeutic strategies targeting Hspb1 and Nrf2 in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
- School of Clinical Medicine, Peking University Health Science Center, Beijing 100191, China.
- Institute of Translational Medicine, College of Medicine, Qingdao University, Qingdao, Shandong 266023, China.
- The State Key Laboratories of Natural and Biomimetic Drugs and Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China.
- Department of Biomedical Informatics, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, 100191, China.
Zitieren
APA
Meng, J., Fang, J., Bao, Y., Chen, H., Hu, X., Wang, Z., Li, M., Cheng, Q., Dong, Y., Yang, X., Zou, Y., Zhao, D., Tang, J., Zhang, W., & Chen, C. (2024). The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease. Theranostics. https://doi.org/10.7150/thno.98457
Vancouver
Meng J, Fang J, Bao Y, Chen H, Hu X, Wang Z, et al. The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease. Theranostics. 2024. doi:10.7150/thno.98457
BibTeX
@article{Meng2024,
author = {Meng, Jieyi and Fang, Jinyu and Bao, Yutong and Chen, Huizhu and Hu, Xiaodan and Wang, Ziyuan and Li, Man and Cheng, Quancheng and Dong, Yaqiong and Yang, Xiaoda and Zou, Yushu and Zhao, Dongyu and Tang, Jiping and Zhang, Weiguang and Chen, Chunhua},
title = {The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.98457}
}
EUVIMED